Fertility drugs, reproductive strategies and ovarian cancer risk

J Ovarian Res. 2014 May 8:7:51. doi: 10.1186/1757-2215-7-51. eCollection 2014.

Abstract

Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers has aroused much interest in recent years. The evaluation of cancer risk among women treated for infertility is very complex, mainly because of many factors that can contribute to occurrence of cancer in these patients (including parity status). This article addresses the possible association between the use of fertility treatments and the risk of ovarian cancer, through a scrupulous search of the literature published thus far in this field. Our principal objective was to give more conclusive answers on the question whether the use of fertility drug significantly increases ovarian cancer risk. Our analysis focused on the different types of drugs and different treatment schedules used. This study provides additional insights regarding the long-term relationships between fertility drugs and risk of ovarian cancer.

Keywords: Clomiphene citrate; Fertility drugs; Ovarian cancer; Ovarian stimulation; in vitro fertilization.

Publication types

  • Review

MeSH terms

  • Clomiphene / adverse effects*
  • Clomiphene / therapeutic use
  • Female
  • Fertility Agents, Female / adverse effects*
  • Fertility Agents, Female / therapeutic use
  • Fertilization in Vitro / adverse effects
  • Humans
  • Infertility, Female / therapy
  • Ovarian Neoplasms / chemically induced*
  • Risk Factors

Substances

  • Fertility Agents, Female
  • Clomiphene